Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trillium Group is a Rochester-based venture capital and executive management firm that specializes in early-stage technology commercialization. Through its University Technology Fund (UTF), the firm focuses on identifying and investing in promising intellectual property emerging from research universities and institutions. Trillium Group provides not only capital but also strategic management and operational support to transform academic innovations into viable commercial enterprises, with a significant portion of its portfolio dedicated to life sciences, medical devices, and biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trillium Group's University Technology Fund.